Related references
Note: Only part of the references are listed.Immune checkpoint inhibitors in cancer therapy: a focus on T-regulatory cells
Varun Sasidharan Nair et al.
IMMUNOLOGY AND CELL BIOLOGY (2018)
Dual inhibition of STAT1 and STAT3 activation downregulates expression of PD-L1 in human breast cancer cells
Varun Sasidharan Nair et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2018)
DNA methylation and repressive H3K9 and H3K27 trimethylation in the promoter regions of PD-1, CTLA-4, TIM-3, LAG-3, TIGIT, and PD-L1 genes in human primary breast cancer
Varun Sasidharan Nair et al.
CLINICAL EPIGENETICS (2018)
Altered expression of major immune regulatory molecules in peripheral blood immune cells associated with breast cancer
Kosuke Kawaguchi et al.
BREAST CANCER (2017)
Immune Checkpoints as a Target for Colorectal Cancer Treatment
Alessandro Passardi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Epigenetics and immunotherapy: The current state of play
Jennifer Dunn et al.
MOLECULAR IMMUNOLOGY (2017)
Preferential accumulation of regulatory T cells with highly immunosuppressive characteristics in breast tumor microenvironment
Azharuddin Sajid Syed Khaja et al.
ONCOTARGET (2017)
PD-1 mRNA expression in peripheral blood cells and its modulation characteristics in cancer patients
Wei Wang et al.
ONCOTARGET (2017)
Expression of PD-1/PD-L1 and PD-L2 in peripheral T-cells from non-small cell lung cancer patients
Oscar Arrieta et al.
ONCOTARGET (2017)
Intratumoral FoxP3+Helios+ Regulatory T Cells Upregulating Immunosuppressive Molecules Are Expanded in Human Colorectal Cancer
Azharuddin Sajid Syed Khaja et al.
FRONTIERS IN IMMUNOLOGY (2017)
DNA methylation and repressive histones in the promoters of PD-1, CTLA-4, TIM-3, LAG-3, TIGIT, PD-L1, and galectin-9 genes in human colorectal cancer
Varun Sasidharan Nair et al.
CLINICAL EPIGENETICS (2017)
Cancer Statistics, 2017
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Targeting immune checkpoints in breast cancer: an update of early results
Cinzia Solinas et al.
ESMO OPEN (2017)
Role of TET enzymes in DNA methylation, development, and cancer
Kasper Dindler Rasmussen et al.
GENES & DEVELOPMENT (2016)
Expression of immune checkpoints in T cells of esophageal cancer patients
Xie Jinhua et al.
ONCOTARGET (2016)
PD-L1 expression on immune cells, but not on tumor cells, is a favorable prognostic factor for head and neck cancer patients
Hye Ryun Kim et al.
SCIENTIFIC REPORTS (2016)
Frequent expression of PD-L1 on circulating breast cancer cells
Martine Mazel et al.
MOLECULAR ONCOLOGY (2015)
Immune Checkpoint Modulation in Colorectal Cancer: What's New and What to Expect
Julie Jacobs et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2015)
The Immunoreceptor TIGIT Regulates Antitumor and Antiviral CD8+ T Cell Effector Function
Robert J. Johnston et al.
CANCER CELL (2014)
VISTA Is an Immune Checkpoint Molecule for Human T Cells
J. Louise Lines et al.
CANCER RESEARCH (2014)
PD-1 expression on peripheral blood T-cell subsets correlates with prognosis in non-small cell lung cancer
Kayoko Waki et al.
CANCER SCIENCE (2014)
Treg Cells Expressing the Coinhibitory Molecule TIGIT Selectively Inhibit Proinflammatory Th1 and Th17 Cell Responses
Nicole Joller et al.
IMMUNITY (2014)
Cutting Edge: TIGIT Has T Cell-Intrinsic Inhibitory Functions
Nicole Joller et al.
JOURNAL OF IMMUNOLOGY (2011)
The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity
Noa Stanietsky et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Share Paper
